Patient education does not impact apixaban adherence

Adherence to the oral anticoagulant apixaban among patients with atrial fibrillation was no better for those who received an educational program compared to those who did not, results of the international, randomised AEGEAN trial show. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail